Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery
Open Access
- 1 August 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 129, 111-121
Abstract
No abstract availableKeywords
Funding Information
- Innovative Medicines Initiative Joint Undertaking (115363)
- European Union's Seventh Framework Programme
This publication has 38 references indexed in Scilit:
- Frontiers of transcutaneous vaccination systems: Novel technologies and devices for vaccine deliveryVaccine, 2013
- Designing Tomorrow's VaccinesNew England Journal of Medicine, 2013
- Microneedle technologies for (trans)dermal drug and vaccine deliveryJournal of Controlled Release, 2012
- License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systemsEuropean Journal of Pharmaceutical Sciences, 2012
- Particulate vaccines: on the quest for optimal delivery and immune responseDrug Discovery Today, 2011
- Small is beautiful: N-trimethyl chitosan–ovalbumin conjugates for microneedle-based transcutaneous immunisationVaccine, 2011
- Programming the magnitude and persistence of antibody responses with innate immunityNature, 2011
- TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile EncephalitisThe Journal of Immunology, 2010
- Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid FormulationsPharmaceutical Research, 2010
- Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunityVaccine, 2008